These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Inhibition of in vitro lymphocyte blastogenesis by inhibitor produced by cultured human lymphoblasts.
    Author: Hersh EM, McCredie KB, Freireich EJ.
    Journal: Clin Exp Immunol; 1974 Jul; 17(3):463-73. PubMed ID: 4283280.
    Abstract:
    Normal human lymphoblastoid cell lines, growing in continuous suspension culture, produce inhibitors of in vitro lymphocyte blastogenesis. The inhibitor reduces human lymphocyte blastogenic responses to phytohaemagglutinin, streptolysin-O and the mixed lymphocyte culture 90–99%, is non-cytotoxic and can inhibit both newly initiated and on-going responses. The inhibitor is heat-stable at 80°C but labile at 100°C, non-dialysable and degraded by pronase but not DNase or RNase. It is species- and tissue-specific and does not inhibit the proliferation of mouse lymphocytes, human melanoma cells or human bone marrow in vitro colony-forming cells. Inhibitor was produced only under very specific conditions of crowding. Thus, maximal inhibitor production occurred at 5 × 106 lymphocytes per cm2 culture surface area while only 0–5% of the maximal amount was produced at 106 or 5 × 107 lymphoblasts per cm2. This data is relevant to the nature of feedback control of immunological reactions and may guide the development of new classes of immunosuppressants.
    [Abstract] [Full Text] [Related] [New Search]